Advertising
BioPharm International offers custom-designed programs to fit the needs of your brand. By utilizing our omnichannel marketing levers you will have access to our highly engaged audience and receive guaranteed, quality results.
Fill out the form below & our team will reach out directly.
Advertisement
Advertisement
Trending on BioPharm International
1
ImvivaBio’s Dual-Target Allogeneic CAR-T Sustains Lupus Remission Through 12 Months
2
Amgen’s Dazodalibep Reduces Systemic Disease Activity in Phase 3 Sjögren’s Trial
3
The BioPharm Brief: Base Editing Hits Its Mark in Sickle Cell, a Phase 3 Win in Sjögren’s, and Off-the-Shelf CAR-T in Lupus
4
Beam's Risto-cel Meets Primary Endpoint in Sickle Cell Trial
5